|
STAM expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.577050E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.424400E-03 |
| Normal-vs-Stage2 |
6.232500E-02 |
| Normal-vs-Stage3 |
2.910200E-01 |
| Normal-vs-Stage4 |
6.824200E-01 |
| Stage1-vs-Stage2 |
5.839000E-01 |
| Stage1-vs-Stage3 |
4.301400E-01 |
| Stage1-vs-Stage4 |
4.590800E-01 |
| Stage2-vs-Stage3 |
7.349400E-01 |
| Stage2-vs-Stage4 |
6.051200E-01 |
| Stage3-vs-Stage4 |
8.284000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.173700E-04 |
| Normal-vs-AfricanAmerican |
3.401000E-01 |
| Normal-vs-Asian |
3.122000E-01 |
| Caucasian-vs-AfricanAmerican |
2.101800E-01 |
| Caucasian-vs-Asian |
5.630800E-01 |
| AfricanAmerican-vs-Asian |
9.333600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.35140000000023E-05 |
| Normal-vs-Female |
9.893200E-01 |
| Male-vs-Female |
5.103800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.572000E-01 |
| Normal-vs-Extreme_Weight |
2.36939999999075E-05 |
| Normal-vs-Obese |
3.467900E-02 |
| Normal-vs-Extreme_Obese |
1.998350E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.768200E-01 |
| Normal_Weight-vs-Obese |
9.361000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.854200E-01 |
| Extreme_Weight-vs-Obese |
6.531600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.297400E-01 |
| Obese-vs-Extreme_Obese |
6.098000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.405200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.155700E-02 |
| Normal-vs-Age(61-80Yrs) |
1.647190E-04 |
| Normal-vs-Age(81-100Yrs) |
1.581090E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.166200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.537740E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.382000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.892500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.842190E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.744000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.50898999999871E-05 |
| Normal-VS-Type2 PRCC |
3.655600E-01 |
| Normal-VS-KIRP CIMP |
1.445790E-01 |
| Normal-VS-Unclassified PRCC |
4.928200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.966300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.62875999999423E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
3.399700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.511970E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.328800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.965500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.032000E-02 |
| Normal-vs-N1 |
4.392200E-01 |
| Normal-vs-N2 |
9.455000E-01 |
| N0-vs-N1 |
3.042000E-01 |
| N0-vs-N2 |
5.295600E-01 |
| N1-vs-N2 |
8.512000E-01 |
|
|
